Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Apitope International N.V.
DescriptionCombination of two peptides derived from Factor VIII
Molecular Target
Mechanism of ActionFactor VIII inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation U.S. - Orphan Drug (Treat hemophilia A);
EU - Orphan Drug (Treat hemophilia A)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today